Nephrology & Urology Flashcards
# #
Normal PaCO2
35-45 mmHg
Normal PaO2
85%
Normal HCO3
22-32 mmol/L
Normal PH
7.40-7.45
urinary urgency + urinary frequency + nocturia
Overactive bladder
Peaked T-waves are seen in lead V2,V3,V4 and V5 + widening of QRS, decreased amplitude of P waves
hyperkalaemia
ACE inhibitors + spironolactone
Increased risk of hyperkalaemia
Causes of hyperkalaemia
– Renal failure.
– Metabolic acidosis.
– Addison’s disease.
– Use of aldosterone antagonists like spironolactone.
– ACEi.
– NSAIDs.
Renal stone recurrence management
- Increase water intake about 2.5 to 3 litres/day
- calcium-rich foods
- thiazide diuretics
- lewer oxalate-rich foods (Oxalate stones)
- Allopurinol
- urinary alkaliniser (potassium citrate)
Renal stones initial investigation
1st case: CT KUB
2nd recurrent: ultrasound + X-ray KUB
Renal stones diagnostic investigation
spiral CT KUB non-contrast
alkaline urine + “Staghorn calculi”
Struvite stones
Proteus pathogen renal stone
Struvite
-magnesium ammonium phosphate
Uric acid stone treatment
- Allopurinol
- urine alkalinization
Oxalate stone treatment
Renal stones in renal pelvis management
< 2.5cm: Extracorporeal lithotripsy
< 2.5cm: Percutaneous lithotripsy
Renal stones in ureter
Upper half < 1cm: Lithotripsy
Upper half: >1 cm: Lithotripsy or nephrolithotomy
Lower half < 1cm: Lithotripsy
Lower half > 1cm: Lithotripsy or endoscopy
Renal stones in bladder
< 3cm: Transurethral lithotomy
> 3cm: Cystotomy
Low potassium + hypertension
Investigate serum aldosterone
Most common complication of radical prostatectomy
Erectile Dysfunction (ED)
Premature ejaculation treatment
1st line: SSRI (raises orgasm threshold)
main complication of retroperitoneal lymph node dissection (RPLND)
Retrograde ejaculation
most common complication of TURP
Urinary tract infection (UTI)
UTI requiring hospitalisation
any infant < than 3 months
- increased risk of urosepsis
Infant UTi treatment
- IV trimethoprim/gentamicin, benzyl penicillin
Erectile Dysfunction (ED) management
Initial :
- Optimise modifiable risk factors / related comorbidities (HTN, DM, diet/exercise etc)
- Treat reversible causes
(Low testosterone, Medication-induced erectile dysfunction, Psychogenic erectile dysfunction – consider referral to a therapist)
- Pharmacological/Surgical treatment
- 1st line: phosphodiesterase type 5 inhibitor (sildenafil)
- 2nd line: penile injections, vacuum erection devices, external shock wave lithotripsy
3rd line: penile prosthesis
polycystic kidney disease features
- Polyuria and nocturia
– Renal failure
– Hypertension
– Abdominal wall and inguinal hernias
– Colonic diverticulosis
– Hepatic cysts
– Subarachnoid or cerebral haemorrhage
– Cardiac anomalies including mitral valve prolapse
albuminuria in diabetes
first void spot specimen Urinary albumin to creatinine (ACR) ratio
URTI + proteinuria + haematuria + immediate onset
IgA nephropathy
IgA nephropathy treatment
Asymptomatic microscopic haematuria: 2 positive
UAs out of 3 in 2-3 weeks
Symptomatic: corticosteroids
URTI + proteinuria + haematuria + onset within weeks + facial oedema
Poststreptococcal glomerulonephritis (PSGN)
HIV px + taking indinavir + haematuria + loin pain
Indinavir induced nephrolithiasis
- Only detectable on US
- Remove/Change indinavir
onset within weeks + HIV hx + haematuria + proteinuria
Focal segmental glomerulosclerosis (FSGS)
HIV-associated nephropathy (HIVAN)
-Nephrotic range proteinuria
-Azotaemia
-Normal to large kidneys on ultrasound images
-Focal segmental glomerulosclerosis (FSGS)
shortened QTc interval on ECG
Severe hypercalcaemia
Dialysis indications
- Pericarditis or pleuritis (urgent indication).
- Progressive uraemic encephalopathy or neuropathy (confusion,
asterixis, myoclonus, wrist or foot drop, or, in severe cases, seizures (urgent indication). - A clinically significant bleeding diathesis attributable to uraemia (immediate indication).
- Persistent metabolic disturbances that are refractory to medical therapy (hyperkalemia, metabolic acidosis, hypercalcemia,hypocalcemia,
hyperphosphatemia) - Fluid overload refractory to diuretics
Dialysis metabolic abnormalities
- hyperphosphatemia
- Vitamin D deficiency
- hypocalcaemia
- secondary hyperparathyroidism
- hyperphosphataemia
Dialysis skeletal abnormalities
renal osteodystrophy:
- Osteomalacia
- osteosclerosis
- osteitis fibrosa cystica
Most common acute complication of haemodialysis
Hypotension
Paradoxical hypertension
Increase dialysis duration
Acute renal failure risk
- Advanced liver cirrhosis
- Ascites medication
Chronic renal failure risk
- Ischemic heart disease
- Type 2 DM
Most common neurologic complication of chronic renal failure
Peripheral neuropathy
Hypercalcaemia manifestations
- constipation
- anorexia
- nausea and vomiting
- abdominal pain
- ileus
– Bone pain.
– Muscular weakness - Peptic ulceration.
– Pancreatitis.
– Neurological - Short QT interval on ECG
renal impairment:
- polyuria, nocturia, and
polydipsia
> Ca 3mmol/L:
- emotional labiality
- confusion,
- delirium
- depression/psychosis
- stupor
- coma
Hypercalcaemia risk factors
Paraneoplastic syndromes:
- squamous cell carcinoma of the head and neck
- Renal cell carcinoma
- Carcinoma of lung
- Multiple myeloma
Hypocalcaemia manifestations
- Paraesthesia and numbness of the fingertips and perioral area.
-Chvostek’s sign: Twitching of the ipsilateral facial musculature (perioral, nasal, and eye muscles) by tapping over cranial nerve VII at the ear.
-Trousseau’s sign: carpal spasm induced by inflation of the blood pressure cuff around the arm.
-Spontaneous muscle cramps.
-Tetany is seen in severe hypocalcaemia
Causes of confusion in kidney disease
without spasm: uraemia
with spasms: hypercalcaemia
Treatment of urge incontinence
**1st line: Bladder retraining
2nd line: TCA/intravesical botulism
3rd line: Surgery
Haematuria+ hypertension + bilateral palpable
kidneys + abdomen and flank fullness
Polycystic kidney disease (PCKD)
autosomal dominant polycystic kidney disease (ADPKD) dx
Presence of 2 or more cysts in each kidney
autosomal dominant polycystic kidney disease (ADPKD) complications
cerebral aneurysms
Polycystic kidney disease (PCKD) high BP mechanism
increased activity of renin angiotensin system
Polycystic kidney disease (PCKD) risk factors
– Younger age dx
– Black Race.
– Male sex.
– Presence of polycystin-1 mutation.
– Hypertension.
Good cyst penetration medication
Fluoroquinolones
(lipid soluble)
Painless haematuria investigation protocol
- urine
microscopy and culture to rule out urinary tract infection - serum electrolytes, urinary proteins, red cell casts in the urine and check BP to rule out glomerulonephritis
- urinary tract US and
cystoscopy - CT abdomen non contrast
Scrotal lumps investigation
malignant unless proven otherwise
initial: US
lab test for tumour markers:
1. The beta subunit of beta-hCG
2. AFP
3. actate dehydrogenase (LDH)
most common
cause of lower urinary tract symptoms (LUS)
Benign prostate hyperplasia (BPH)
Benign prostate hyperplasia (BPH) management
- 1st line: Finasteride that needs to be bridged with selective α-blocker such as doxazosin, terazosin, or pprazosin
- gold standard: Transurethral resection of the prostate (TURP)
Benign prostate hyperplasia (BPH) complications
hydronephrosis and kidney damage
Most common expected Longterm complication of TURP
Retrograde ejaculation 80-90%
lower urinary tract symptoms (LUS) symptoms
Filling:
-urinary frequency,
- urgency,
- dysuria,
- nocturia.
Voiding:
- poor stream
- hesitancy
- terminal dribbling,
- incomplete voiding
- overflow incontinence (occurs in chronic retention)
fever + perineal region pain + frequency, urgency, dysuria + oliguria + leukocytosis + prostate tenderness + with/o hypotension and tachycardia
Prostatitis
Prostatitis treatment
Borad spectrum antibiotics for 3 weeks
elderly patient + sclerotic changes in vertebrae and pelvis
Prostatic cancer
Prostate cancer T staging
T1 - impalpable
T2 - confined to one nodule
T3a - outside capsule
T3b - into seminal vesicle
Prostate cancer active surveillance criteria
- PSA ≤ 10.0 ng/mL
- clinical stage T1–2a
- Gleason score ≤ (3 + 4 = 7) and pattern 4 component < 10% after pathological review
Prostate cancer active surveillance protocol
- PSA measurements every 3 months
- PE + DRE every 6 months
- Repeat prostate biopsy within 6–12 months of starting protocol
Prostate PSA
40–49 years: <2.5 ng/mL
50–59 years: <3.5
60–69 years: <4.5
70+ years: <6.5
Gleason grade
1: mild - no intervention
2:-3 moderate - conservative measures
3-5: high - requiring surgical intervention
Gleason score
< 6: low risk
7 (3+4)
7 (4+3)
8
9-10
urethral injury initial investigation
retrograde urethrogram followed by Foley (bladder or urinary) catheter
indwelling catheter (Foley) contraindications
Pelvic injury with urethral meatus blood
suprapubic catheter contraindications
– Coagulopathy
– Urinary Bladder carcinoma
– Pregnancy
– Ascites
– Severe obesity
– Lower abdominal scar tissue, mesh or adhesions from previous surgeries, pelvic cancer or radiation treatment
testicular torsion management
Immediate surgery to prevent infarction
testicular tumour malignancy investigation
- scrotal ultrasound
with colour Doppler - CT abdomen and chest x-ray
- inguinal orchiectomy